Amulet Capital Partners Acquires United Vein & Vascular Centers
November 30, 2022
Amulet Capital Partners, a middle-market healthcare-focused private equity firm, has acquired United Vein & Vascular Centers (UVVC), a Tampa-based provider of outpatient vascular care operating more than 30 clinic locations. Amulet will partner with founder and CEO Dr. Gamal Wazni and management to expand UVVC’s national footprint, add new clinics and broaden its treatment capabilities.
- Buyers
- Amulet Capital Partners, LP
- Targets
- United Vein & Vascular Centers
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Petra Capital Partners and Canopy Capital Partners Complete Growth Recapitalization of American Vascular Associates
April 26, 2023
Healthcare Services
American Vascular Associates (AVA), a Palm Harbor, Florida-based network of outpatient vascular and endovascular centers, completed a growth recapitalization with Petra Capital Partners and Canopy Capital Partners. The investment will support AVA's accelerated growth, expansion of outpatient labs and ambulatory surgery centers, and additional physician partnerships while existing management remains shareholders.
-
Nordic Capital Acquires Atlantic Street Capital's Stake in United Veterinary Care
April 23, 2021
Healthcare Services
Nordic Capital has agreed to invest in United Veterinary Care (UVC), acquiring the shareholdings controlled by Atlantic Street Capital and joining UVC's veterinary owner-practitioners as a major shareholder. UVC is a Palm Beach Gardens, Florida–based multi-location veterinary group operating more than 60 hospitals across 13 U.S. states with over 1,200 employees; the transaction supports the company's continued organic and acquisitive growth.
-
Amulet Capital Partners Acquires Alliance Clinical Network
May 22, 2023
Healthcare Services
Amulet Capital Partners has acquired Alliance Clinical Network (ACN), a Dallas-based clinical site platform that owns and operates six research sites across California, Nevada and Texas. ACN will continue to be led by founder and CEO Anthony Abey (who retains a significant ownership stake) and will partner with Amulet to expand its footprint, therapeutic capabilities and strategic acquisitions to serve pharmaceutical sponsors and CROs.
-
Amulet Capital Partners Acquires Eruptr
February 7, 2023
Healthcare Services
Amulet Capital Partners has acquired Eruptr, a Bradenton, Florida–based provider of technology-enabled healthcare digital marketing and SaaS health risk assessments, with Athyrium Capital Management investing alongside Amulet. Eruptr was previously a portfolio company of H.I.G. Growth Partners; the deal positions Eruptr to expand its patient acquisition, engagement and SaaS offerings under Amulet's healthcare-focused platform.
-
Amulet Capital Partners Acquires Genetics & IVF Institute
September 6, 2024
Healthcare Services
Amulet Capital Partners has acquired the Genetics & IVF Institute (GIVF), a leading provider of reproductive tissue banking and related reproductive technology services, including Fairfax Cryobank and Fairfax EggBank. The private equity investment—made with significant co-investment from a consortium of Amulet limited partners—will support GIVF's growth, platform and capability expansion to broaden access to fertility services and donor-tissue offerings.
-
Bluestem Equity Acquires United Vision Logistics
December 28, 2022
Transportation
Bluestem Equity Ltd. completed the acquisition of Lafayette, Louisiana-based United Vision Logistics (UVL), a land transportation and logistics provider offering heavy haul, long haul, and expedited services across the United States and Canada. UVL — which operates out of Lafayette and Houston and maintains a network of over 100 facilities and a large fleet of owner-operators and partnered carriers — will continue operating under its existing leadership as Bluestem partners to grow the business.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.